The global home healthcare market could be worth $839 billion by 2028, says Zion Market Research, which could be a significant catalyst for companies such as Quipt Home Medical Corp. (NASDAQ: QIPT) (TSXV: QIPT), Amedisys Inc. (NASDAQ: AMED), LHC Group Inc. (NASDAQ: LHCG), Savaria Corporation (TSX: SIS) (OTC: SISXF), and Addus Homecare Corporation (NASDAQ: ADUS).
In addition, obesity, smoking, an aging population, and pandemic-related illnesses are reportedly contributing to a rise in the need for home therapeutic respiratory devices. From the onset of chronic obstructive pulmonary disease (COPD) to the demand for continuous positive airway pressure (CPAP) machines, the prevalence of respiratory disorders is pushing the device market to a valuation of $47 billion and projections to reach more than $68 billion by 2032, according to a study by Future Market Insights.